HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

WCID 2022

Respiratory Virus Surveillance among Outpatients in Rural Zambia in 2021

Evan Miller, Speaker at Infectious Diseases Conferences
Johns Hopkins University, United States
Title : Respiratory Virus Surveillance among Outpatients in Rural Zambia in 2021

Abstract:

Background: Respiratory infections are a major cause of morbidity and mortality globally but are relatively understudied in sub-Saharan Africa.To assess the diversity, prevalence and pathogen composition of circulating respiratory viruses amongst symptomatic outpatients in rural Zambia, we analyzed samples from an existing influenza-like illness (ILI), influenza virus (IV) and respiratory syncytial virus (RSV) surveillance program established in 2018 at Macha Hospital in Zambia.

Methods: Nasopharyngeal (NP) samples were collected year-round from outpatients with ILI and tested onsite for Influenza A and B viruses (IAV and IBV), RSV, and SARS-CoV-2 using Xpert Xpress SARS-CoV-2/Flu/RSV (Cepheid, Sunnyvale, CA). Samples were additionally tested for the presence of other respiratory viruses by ePlex RP 2.0 (Genmark Diagnostics, Carlsbad, CA) using a novel capture and concentration sample processing methodology.

Results: IAV was detected from March to December (overall prevalence: 9.4%), with a peak (36.7%) in June. IBV was detected from June to December (overall prevalence: 12.5%), with a peak (54.3%) in September. RSV was detected from January to April (overall prevalence: 18.7%), with a peak (66.0%) in February. SARS-CoV-2 was detected throughout the year (overall prevalence: 4.1%), with a peak (16.5%) in December. The overall Rhinovirus/enterovirus (Rhv/Ev) was detected throughout the year (overall prevalence: 23.6%), with multiple peaks in March, April and October. Parainfluenza (PiV) had an overall prevalence of 9.8% with a peak in July (27.1%). Adenovirus (AdV) had an overall prevalence of 6.6% with a peak in June (28.8%), while non-SARS-CoV-2 seasonal coronaviruses (CoV, 229E, HKU1, OC43, NL63) had an overall prevalence of 4.3% with a peak in November (23.8%).  Lastly, metapneumovirus (hMpV) had an overall prevalence of 2.5% with a peak in November (10.1%). Among participants tested with ePlex, a virus was identified in 76.5% of samples, including 11.5% where ≥2 viruses were identified. The most common coinfections were Rhv/Ev with either AdV (20.7%) or PiV (20.7%).

Conclusion: We found a broad diversity of viruses in addition to those detected by routine surveillance (IVs, RSV, SARS-CoV-2) in this population.  The burden of respiratory viruses in this population can be significant, and depending on the time of year, may be contributed by multiple organisms.

Biography:

Mr. Miller is a lab assistant at the Johns Hopkins University School of Medicine Department of Infectious Diseases. During the year, he attends Johns Hopkins University and is pursuing a Bachelor’s degree in Mathematics while taking pre-requisities for Medical School. After graduating from Talmudical Academy High School in 2017, he attended Yeshivas Toras Moshe, a Talmudic text-based institution, for three years. He has volunteered at a Bio-fluidics Lab and at the University of Maryland Shock Trauma Unit and tutors high school students in advanced Talmudic text. In his free time, he enjoys playing tennis and singing.

Newsletter

By signing up, you agree to join our mailing list to receive information and updates.

Watsapp